Retatrutide, a experimental dual stimulator of the GLP-1 target and glucose-dependent secreted polypeptide (GIP) receptor , is demonstrating promising results in preliminary patient trials . Ongoing https://minibookmarking.com/story21488697/retatrutide-emerging-studies-and-potential-medical-applications